Mechanisms involved in lung cancer development in COPD

Abdel-Aziz, 2008, Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study, J Cancer Res Clin Oncol, 134, 777, 10.1007/s00432-007-0345-3 Abidoye, 2007, Lung carcinoma in African Americans, Nat Clin Pract Oncol, 4, 118, 10.1038/ncponc0718 Adcock, 2006, Kinase inhibitors and airway inflammation, Eur J Pharmacol, 533, 118, 10.1016/j.ejphar.2005.12.054 Adcock, 2006, Epigenetics and airways disease, Respir Res, 7, 21, 10.1186/1465-9921-7-21 Agúndez, 2008, Polymorphisms of human N-acetyltransferases and cancer risk, Curr Drug Metab, 9, 520, 10.2174/138920008784892083 Alyaqoub, 2006, Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT), Carcinogenesis, 27, 2442, 10.1093/carcin/bgl088 Amos, 2008, Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1, Nat Genet, 40, 616, 10.1038/ng.109 Anderson, 2003, Acquired somatic mutations in the molecular pathogenesis of COPD, Trends Pharmacol Sci, 24, 71, 10.1016/S0165-6147(02)00052-4 Anthonisen, 2005, The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial, Ann Intern Med, 142, 233, 10.7326/0003-4819-142-4-200502150-00005 Arif, 2008, COX2 and p53 risk-alleles coexist in COPD, Clin Chim Acta, 397, 48, 10.1016/j.cca.2008.07.010 Auerbach, 1979, Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs. 1970–1977, N Engl J Med, 300, 381, 10.1056/NEJM197902223000801 Bailey-Wilson, 2004, A major lung cancer susceptibility locus maps to chromosome 6q23-25, Am J Hum Genet, 75, 460, 10.1086/423857 Balansky, 2006, Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine, Proc Natl Acad Sci U S A, 103, 7823, 10.1073/pnas.0601412103 Balansky, 2010, Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine, Int J Cancer, 126, 1047 Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 Barnes, 2004, Alveolar macrophages as orchestrators of COPD, COPD, 1, 59, 10.1081/COPD-120028701 Beane, 2009, Clinical impact of high-throughput gene expression studies in lung cancer, J Thorac Oncol, 4, 109, 10.1097/JTO.0b013e31819151f8 Belinsky, 1998, Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis, Proc Natl Acad Sci U S A, 95, 11891, 10.1073/pnas.95.20.11891 Belinsky, 2002, Aberrant promoter methylation in bronchial epithelium and sputum from current and former smoker, Cancer Res, 62, 2370 Belvisi, 2009, Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease, Br J Pharmacol, 158, 994, 10.1111/j.1476-5381.2009.00373.x Ben-Zaken Cohen, 2007, The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism, Am J Respir Crit Care Med, 176, 113, 10.1164/rccm.200611-1655PP Brock, 2008, DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med, 358, 1118, 10.1056/NEJMoa0706550 Brody, 2006, State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer, Proc Am Thorac Soc, 3, 535, 10.1513/pats.200603-089MS Calikoglu, 2006, The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population, Biochem Genet, 44, 307, 10.1007/s10528-006-9031-4 Calverley, 2007, Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, 356, 775, 10.1056/NEJMoa063070 Campa, 2004, Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer, Carcinogenesis, 25, 229, 10.1093/carcin/bgh008 Cappuzzo, 2010, SATURN investigators. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study, Lancet Oncol, 11, 521, 10.1016/S1470-2045(10)70112-1 Caramori, 2006, Gene-environment interactions in the development of chronic obstructive pulmonary disease, Curr Opin Allergy Clin Immunol, 6, 323, 10.1097/01.all.0000244791.18486.f7 Caramori, 2004, Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD, Curr Opin Invest Drugs, 5, 1141 Caramori, 2007, Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer, Expert Rev Respir Med, 1, 171, 10.1586/17476348.1.2.171 Card, 2009, Hormonal influences on lung function and response to environmental agents: lessons from animal models of respiratory disease, Proc Am Thorac Soc, 6, 588, 10.1513/pats.200904-020RM Carlisle, 2007, Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells, Pulm Pharmacol Ther, 20, 629, 10.1016/j.pupt.2006.07.001 Carney, 2002, Lung cancer—time to move on from chemotherapy, N Engl J Med, 346, 126, 10.1056/NEJM200201103460211 Chen, 2008, Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD, Respirology, 13, 1014 Cheng, 2009, Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease, Biochem Genet, 47, 591, 10.1007/s10528-009-9252-4 Coté, 2005, Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer, JAMA, 293, 3036, 10.1001/jama.293.24.3036 D’Agostini, 2009, Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice, Cancer Prev Res (PhilaPa), 2, 546, 10.1158/1940-6207.CAPR-08-0235 Dance-Barnes, 2009, Lung tumor promotion by curcumin, Carcinogenesis, 30, 1016, 10.1093/carcin/bgp082 Decramer, 2005, Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial, Lancet, 365, 1552, 10.1016/S0140-6736(05)66456-2 Denlinger, 2004, Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer, J Thorac Cardiovasc Surg, 127, 1078, 10.1016/S0022-5223(03)01321-7 Dialyna, 2003, Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk, Oncol Rep, 10, 1829 Di Stefano, 2002, Increased expression of NF-κB in bronchial biopsies from smokers and patients with chronic obstructive pulmonary disease (COPD), Eur Resp J, 20, 556, 10.1183/09031936.02.00272002 Doll, 2005, Mortality in relation to alcohol consumption: a prospective study among male British doctors, Int J Epidemiol, 34, 199, 10.1093/ije/dyh369 Dovey, 2008, Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion, Proc Natl Acad Sci U S A, 105, 11857, 10.1073/pnas.0803574105 Dubey, 2009, Update in lung cancer 2008, Am J Respir Crit Care Med, 179, 860, 10.1164/rccm.200902-0289UP Egleston, 2009, Population-based trends in lung cancer incidence in women, Semin Oncol, 36, 506, 10.1053/j.seminoncol.2009.09.003 Esteller, 2008, Epigenetics in cancer, N Engl J Med, 358, 1148, 10.1056/NEJMra072067 Etzel, 2003, Risk for smoking-related cancer among relatives of lung cancer patients, Cancer Res, 3, 8531 Falvella, 2009, Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk, Clin Cancer Res, 15, 1837, 10.1158/1078-0432.CCR-08-2107 Fletcher, 2004, Lifetime risk of common cancers among retinoblastoma survivors, J Natl Cancer Inst, 96, 357, 10.1093/jnci/djh058 Foulkes, 2008, Inherited susceptibility to common cancers, N Engl J Med, 359, 2143, 10.1056/NEJMra0802968 Franklin, 1997, Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis, J Clin Invest, 100, 2133, 10.1172/JCI119748 Fu, 2007, Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population, Oncol Rep, 17, 483 Fukumoto, 2005, Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas, Clin Cancer Res, 11, 1776, 10.1158/1078-0432.CCR-04-1238 Gehring, 2009, DNA demethylation by DNA repair, Trends Genet, 25, 82, 10.1016/j.tig.2008.12.001 Giangreco, 2007, Lung cancer and lung stem cells: strange bedfellows?, Am J Respir Crit Care Med, 175, 547, 10.1164/rccm.200607-984PP Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001. NIH Publication No 2701:1-100. Last update 2009. http://www.goldcopd.com (accessed January 22, 2010) Goto, 2009, Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma, Cancer Res, 69, 9073, 10.1158/0008-5472.CAN-09-1595 Goven, 2008, Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema, Thorax, 63, 916, 10.1136/thx.2007.091181 Gresner, 2007, Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer, Lung Cancer, 57, 1, 10.1016/j.lungcan.2007.02.002 Greten, 2004, The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer, Cancer Lett, 206, 193, 10.1016/j.canlet.2003.08.029 Guil, 2009, DNA methylomes, histone codes and miRNAs: tying it all together, Int J Biochem Cell Biol, 41, 87, 10.1016/j.biocel.2008.09.005 Han, 2008, PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-κB signals, Am J Physiol Lung Cell Mol Physiol, 294, L1238, 10.1152/ajplung.00017.2008 Harris, 2009, Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung, Inflammopharmacology, 17, 55, 10.1007/s10787-009-8049-8 Harris, 2005, Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review), Oncol Rep, 13, 559 Hayes, 2006, Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study, Cancer Epidemiol Biomarkers Prev, 15, 2226, 10.1158/1055-9965.EPI-06-0172 Hida, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res, 58, 3761 Hu, 2008, Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses, Respirology, 13, 837, 10.1111/j.1440-1843.2008.01356.x Hu, 2008, Genetic variants of miRNA sequences and non-small cell lung cancer survival, J Clin Invest, 118, 2600 Hung, 2008, A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25, Nature, 452, 633, 10.1038/nature06885 Hwang, 2003, Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk, Hum Genet, 113, 238, 10.1007/s00439-003-0968-7 Islam, 1994, Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan, Cancer Epidemiol Biomarkers Prev, 3, 289 Janssen-Heijnen, 2001, Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe, Lung Cancer, 31, 123, 10.1016/S0169-5002(00)00197-5 Jemal, 2009, Cancer statistics, 2009, CA Cancer J Clin, 59, 225, 10.3322/caac.20006 Kamholz, 2006, Wine, spirits and the lung: good, bad or indifferent?, Trans Am Clin Climatol Assoc, 117, 129 Karin, 2009, NF-kappaB as a critical link between inflammation and cancer, Cold Spring Harbor Perspect Biol, 1, a000141, 10.1101/cshperspect.a000141 Katsimpoula, 2009, Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer, Anticancer Res, 29, 1373 Kaur-Knudsen, 2009, CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals, Pharmacogenet Genomics, 19, 685, 10.1097/FPC.0b013e32833042cb Khan, 2007, Lung cancer chemoprevention with inhaled corticosteroids?, Am J Respir Crit Care Med, 176, 1169, 10.1164/ajrccm.176.11.1169 Kikuchi, 2005, Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism, Hum Genet, 116, 354, 10.1007/s00439-004-1162-2 Kim, 2007, Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells, Am J Physiol Lung Cell Mol Physiol, 293, L1092, 10.1152/ajplung.00015.2007 Kim, 2005, Identification of bronchioalveolar stem cells in normal lung and lung cancer, Cell, 121, 823, 10.1016/j.cell.2005.03.032 Kiri, 2009, Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking, Respir Med, 103, 85, 10.1016/j.rmed.2008.07.024 Komarova, 2005, p53 is a suppressor of inflammatory response in mice, FASEB J, 19, 1030, 10.1096/fj.04-3213fje Lacroix, 2008, Gene expression profiling of non-small-cell lung cancer, Expert Rev Mol Diagn, 8, 167, 10.1586/14737159.8.2.167 Lai, 2009, O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells, Anticancer Res, 29, 2535 Lam, 2007, Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers, Cancer Res, 67, 4638, 10.1158/0008-5472.CAN-06-4628 Lam, 2004, A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium, Clin Cancer Res, 10, 6502, 10.1158/1078-0432.CCR-04-0686 Landi, 2010, MicroRNA expression differentiates histology and predicts survival of lung cancer, Clin Cancer Res, 16, 430, 10.1158/1078-0432.CCR-09-1736 Lee, 2008, Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment, Crit Rev Oncol Hematol, 66, 208, 10.1016/j.critrevonc.2008.01.004 Lee, 2006, Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease, J Lab Clin Med, 147, 228, 10.1016/j.lab.2005.12.008 Lin, 2010, The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy, Expert Opin Ther Targets, 14, 45, 10.1517/14728220903431069 Lips, 2009, Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals, Int J Epidemiol Liu, 2008, Familiar aggregation of common sequence variants on 15q24-25.1 in lung cancer, J Natl Cancer Inst, 100, 1326, 10.1093/jnci/djn268 Lopez, 2006, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data, Lancet, 367, 1747, 10.1016/S0140-6736(06)68770-9 Malhotra, 2008, Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1, Am J Respir Crit Care Med, 178, 592, 10.1164/rccm.200803-380OC Malhotra, 2006, The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women, BMC Pulm Med, 6, 2, 10.1186/1471-2466-6-2 Mannino, 2007, COPD and lung cancer have come a long way…baby, Am J Respir Crit Care Med, 176, 108, 10.1164/rccm.200704-590ED Mannino, 2003, Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up, Arch Intern Med, 163, 1475, 10.1001/archinte.163.12.1475 Marees, 2008, Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up, J Natl Cancer Inst, 100, 1771, 10.1093/jnci/djn394 Martín-Caballero, 2001, Tumor susceptibility of p21(Waf1/Cip1)-deficient mice, Cancer Res, 61, 6234 Martínez-Moreno, 2006, Cholinesterase activity of human lung tumours varies according to their histological classification, Carcinogenesis, 27, 429, 10.1093/carcin/bgi250 Miller, 2007, Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease, Cancer Epidemiol Biomarkers Prev, 16, 2425, 10.1158/1055-9965.EPI-07-0220 Moghaddam, 2009, Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice, Carcinogenesis, 30, 1949, 10.1093/carcin/bgp229 Moghaddam, 2009, Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model, Am J Respir Cell Mol Biol, 40, 443, 10.1165/rcmb.2008-0198OC Molfino, 2008, Gene-environment interactions in chronic obstructive pulmonary disease, Int J Chron Obstruct Pulmon Dis, 3, 491, 10.2147/COPD.S2528 Molina, 2008, Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship, Mayo Clin Proc, 83, 584, 10.4065/83.5.584 Nakamaru, 2009, A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9, FASEB J, 23, 2810, 10.1096/fj.08-125468 Newton, 2007, Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors, J Pharmacol Exp Ther, 321, 734, 10.1124/jpet.106.118125 Nuovo, 1999, In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis, Proc Natl Acad Sci U S A, 96, 12754, 10.1073/pnas.96.22.12754 Ocak, 2009, High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications, Eur Respir J, 34, 489, 10.1183/09031936.00042409 Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth, Cancer Res, 68, 1303, 10.1158/0008-5472.CAN-07-5003 Otsuka, 2008, The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer, J Thorac Oncol, 1379, 10.1097/JTO.0b013e31818dda9d Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol Cell, 21, 689, 10.1016/j.molcel.2006.01.013 Palmisano, 2000, Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res, 60, 5954 Pan, 2008, Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration, J Biol Chem, 283, 623, 10.1074/jbc.M704934200 Papi, 2004, COPD increases the risk of squamous histological subtype in smokers who develop non-small-cell lung cancer, Thorax, 59, 679, 10.1136/thx.2003.018291 Parimon, 2007, Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 175, 712, 10.1164/rccm.200608-1125OC Park, 1999, Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer, J Natl Cancer Inst, 91, 1863, 10.1093/jnci/91.21.1863 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Patel, 2008, International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 178, 500, 10.1164/rccm.200801-059OC Peebles, 2007, Inflammation and lung carcinogenesis: applying findings in prevention and treatment, Expert Rev Anticancer Ther, 7, 1405, 10.1586/14737140.7.10.1405 Pereira, 2007, Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors, Int J Cancer, 120, 1150, 10.1002/ijc.22468 Pieper, 2007, Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide, Life Sci, 80, 2270, 10.1016/j.lfs.2007.02.034 Pierrou, 2007, Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 175, 577, 10.1164/rccm.200607-931OC Pilette, 2007, Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD, Eur Respir J, 29, 914, 10.1183/09031936.00073005 Pleasance, 2010, A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, 463, 191, 10.1038/nature08658 Pleasance, 2010, A small-cell lung cancer genome with complex signatures of tobacco exposure, Nature, 463, 184, 10.1038/nature08629 Popanda, 2007, Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms, Lung Cancer, 55, 25, 10.1016/j.lungcan.2006.09.006 Popanda, 2004, Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer, Carcinogenesis, 25, 2433, 10.1093/carcin/bgh264 Psarras, 2005, Oxidants in asthma and chronic obstructive pulmonary disease (COPD), Curr Pharm Des, 11, 2053, 10.2174/1381612054065774 Punturieri, 2009, Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research, J Natl Cancer Inst, 101, 554, 10.1093/jnci/djp023 Purdue, 2007, Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers, Thorax, 62, 51, 10.1136/thx.2006.064196 Racke, 2004, The airway cholinergic system: physiology and pharmacology, Pulm Pharmacol Ther, 17, 181, 10.1016/j.pupt.2004.03.001 Rajendrasozhan, 2008, SIRT1, an anti-inflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 177, 861, 10.1164/rccm.200708-1269OC Rangasamy, 2004, Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice, J Clin Invest, 114, 1248, 10.1172/JCI200421146 Rauch, 2008, High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer, Proc Natl Acad Sci U S A, 105, 252, 10.1073/pnas.0710735105 Regala, 2009, Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis, Cancer Res, 69, 7603, 10.1158/0008-5472.CAN-09-2066 Reiman, 2007, Tumor immunoediting and immunosculpting pathways to cancer progression, Semin Cancer Biol, 17, 275, 10.1016/j.semcancer.2007.06.009 Ricciardolo, 2005, Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease, J Allergy Clin Immunol, 116, 1028, 10.1016/j.jaci.2005.06.034 Roman, 2004, Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling, FASEB J, 18, 1436, 10.1096/fj.03-0826fje Rotunno, 2009, Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression, PLoS ONE, 4, e5652, 10.1371/journal.pone.0005652 Rundall, 2004, Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death, Surgery, 136, 416, 10.1016/j.surg.2004.05.018 Russo, 2005, Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer, Clin Cancer Res, 11, 2466, 10.1158/1078-0432.CCR-04-1962 Saccone, 2009, The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African–Americans and in European–Americans, Cancer Res, 69, 6848, 10.1158/0008-5472.CAN-09-0786 Sancar, 2004, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints, Annu Rev Biochem, 73, 39, 10.1146/annurev.biochem.73.011303.073723 Sanders, 1989, Non-ocular cancer in relatives of retinoblastoma patients, Br J Cancer, 60, 358, 10.1038/bjc.1989.285 Sato, 2007, A translational view of the molecular pathogenesis of lung cancer, J Thorac Oncol, 2, 327, 10.1097/01.JTO.0000263718.69320.4c Scagliotti, 2009, Nonsmall cell lung cancer in never smokers, Curr Opin Oncol, 21, 99, 10.1097/CCO.0b013e328321049e Schreinemachers, 1994, Aspirin use and lung, colon, and breast cancer incidence in a prospective study, Epidemiology, 5, 138, 10.1097/00001648-199403000-00003 Schwartz, 2009, Chronic obstructive lung diseases and risk of non-small cell lung cancer in women, J Thorac Oncol, 4, 291, 10.1097/JTO.0b013e3181951cd1 Schwartz, 2006, Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 173, 16, 10.1164/rccm.200502-235PP Segal, 2002, Computer simulations of particle deposition in the lungs of chronic obstructive pulmonary disease patients, Inhal Toxicol, 14, 705, 10.1080/08958370290084593 Shacter, 2002, Chronic inflammation and cancer, Oncology (Williston Park), 16, 217 Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, Proc Natl Acad Sci U S A, 105, 13568, 10.1073/pnas.0806268105 Sin, 2007, Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women, Proc Am Thorac Soc, 4, 671, 10.1513/pats.200706-082SD Singh, 2006, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer, PLoS Med, 3, e420, 10.1371/journal.pmed.0030420 Skillrud, 1986, Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study, Ann Intern Med, 105, 503, 10.7326/0003-4819-105-4-503 Slatore, 2009, Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study, Cancer Epidemiol Biomarkers Prev, 18, 1203, 10.1158/1055-9965.EPI-08-1110 Song, 2008, Activated cholinergic signaling provides a target in squamous cell lung carcinoma, Cancer Res, 68, 4693, 10.1158/0008-5472.CAN-08-0183 Song, 2003, Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma, Cancer Res, 63, 214 Song, 2007, M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion, Cancer Res, 67, 3936, 10.1158/0008-5472.CAN-06-2484 Song, 2003, Synthesis of acetylcholine by lung cancer, Life Sci, 72, 2159, 10.1016/S0024-3205(03)00078-X Song, 2008, Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy, J Pharmacol Sci, 106, 180, 10.1254/jphs.FM0070091 Soria, 2002, Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers, Cancer Res, 62, 351 Spange, 2009, Acetylation of non-histone proteins modulates cellular signalling at multiple levels, Int J Biochem Cell Biol, 41, 185, 10.1016/j.biocel.2008.08.027 Spira, 2007, Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer, Nat Med, 13, 361, 10.1038/nm1556 Spitz, 2008, The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer, J Natl Cancer Inst, 100, 1552, 10.1093/jnci/djn363 Spitz, 2003, Genetic susceptibility to lung cancer: the role of DNA damage and repair, Cancer Epidemiol Biomarkers Prev, 12, 689 Stathopoulos, 2007, Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis, Proc Natl Acad Sci U S A, 104, 18514, 10.1073/pnas.0705316104 Stellman, 2001, Smoking and lung cancer risk in American and Japanese men: an international case-control study, Cancer Epidemiol Biomarkers Prev, 10, 1193 Sueoka, 2005, Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction, Lung Cancer, 48, 77, 10.1016/j.lungcan.2004.10.007 Sun, 2009, Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha, Cancer Res, 69, 6445, 10.1158/0008-5472.CAN-09-1001 Suzuki, 2008, Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, 39, 673, 10.1165/rcmb.2007-0424OC Tabak, 2001, Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study), Clin Exp Allergy, 31, 747, 10.1046/j.1365-2222.2001.01064.x Takahashi, 2010, Tobacco smoke promotes lung tumorigenesis by triggering IKKβ- and JNK1-dependent inflammation, Cancer Cell, 17, 89, 10.1016/j.ccr.2009.12.008 Tang, 2006, Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions, Cancer, 107, 2637, 10.1002/cncr.22315 Tashkin, 2008, A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, 359, 1543, 10.1056/NEJMoa0805800 Tauler, 2009, Lung cancer and inflammation: interaction of chemokines and hnRNPs, Curr Opin Pharmacol, 9, 384, 10.1016/j.coph.2009.06.004 Teisanu, 2009, Prospective isolation of bronchiolar stem cells based upon immunophenotypic and autofluorescence characteristics, Stem Cells, 27, 612, 10.1634/stemcells.2008-0838 Thorgeirsson, 2008, A variant associated with nicotine dependence, lung cancer and peripheral arterial disease, Nature, 452, 638, 10.1038/nature06846 Tian, 2009, A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese, Cancer Epidemiol Biomarkers Prev, 18, 1183, 10.1158/1055-9965.EPI-08-0814 Tichelaar, 2005, Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies, BMC Cancer, 5, 155, 10.1186/1471-2407-5-155 Tockman, 1987, Airways obstruction and the risk for lung cancer, Ann Intern Med, 106, 512, 10.7326/0003-4819-106-4-512 Tomita, 2002, Increased p21CIP1/WAF1 and bcl-xL expression and reduced apoptosis in alveolar macrophages from smokers, Am J Respir Crit Care Med, 166, 724, 10.1164/rccm.2104010 Trivers, 1996, Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer, Clin Cancer Res, 2, 1767 Tsuji, 2006, Alveolar cell senescence in patients with pulmonary emphysema, Am J Respir Crit Care Med, 174, 886, 10.1164/rccm.200509-1374OC Tsuji, 2009, Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease, Respiration Tsurutani, 2005, Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells, Carcinogenesis, 26, 1182, 10.1093/carcin/bgi072 Tuder, 2008, Cigarette smoke triggers code red: p21CIP1/WAF1/SDI1 switches on danger responses in the lung, Am J Respir Cell Mol Biol, 39, 1, 10.1165/rcmb.2008-0117TR Turk, 1995, DNA adduct 8-hydroxyl-2′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase, Carcinogenesis, 16, 1253, 10.1093/carcin/16.5.1253 Turner, 2007, Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers, Am J Respir Crit Care Med, 176, 285, 10.1164/rccm.200612-1792OC Valinluck, 2004, Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2), Nucleic Acids Res, 32, 4100, 10.1093/nar/gkh739 van den Berg, 2008, CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone, Lung Cancer, 60, 57, 10.1016/j.lungcan.2007.09.007 van den Berg, 2007, The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium, Am J Respir Crit Care Med, 175, 1061, 10.1164/rccm.200612-1770OC Van Dyke, 2008, Regular adult aspirin use decreases the risk of non-small cell lung cancer among women, Cancer Epidemiol Biomarkers Prev, 17, 148, 10.1158/1055-9965.EPI-07-0517 van Gestel, 2009, COPD and cancer mortality: the influence of statins, Thorax, 64, 963, 10.1136/thx.2009.116731 van Zandwijk, 2000, EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups, J Natl Cancer Inst, 92, 977, 10.1093/jnci/92.12.977 Wasswa-Kintu, 2005, Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis, Thorax, 60, 570, 10.1136/thx.2004.037135 Wattenberg, 2000, Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol, Carcinogenesis, 21, 179, 10.1093/carcin/21.2.179 Wei, 2000, Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study, J Natl Cancer Inst, 92, 1764, 10.1093/jnci/92.21.1764 West, 2003, Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells, J Clin Invest, 111, 81, 10.1172/JCI200316147 Wistuba, 2007, Genetics of preneoplasia: lessons from lung cancer, Curr Mol Med, 7, 3, 10.2174/156652407779940468 Wistuba, 1999, Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma, Oncogene, 18, 643, 10.1038/sj.onc.1202349 Wistuba, 2000, Molecular changes in the bronchial epithelium of patients with small cell lung cancer, Clin Cancer Res, 6, 2604 Wistuba, 1997, Molecular damage in the bronchial epithelium of current and former smokers, J Natl Cancer Inst, 89, 1366, 10.1093/jnci/89.18.1366 Wolff, 1998, Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res, 58, 4997 Wu, 2009, Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations, Cancer Res, 69, 5065, 10.1158/0008-5472.CAN-09-0081 Wu, 2003, hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung, Lung Cancer, 41, 179, 10.1016/S0169-5002(03)00226-5 Wu, 1998, Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations, Cancer Epidemiol Biomarkers Prev, 7, 13 Xaubet, 2004, Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 35 Yang, 2008, Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk, Arch Intern Med, 168, 1097, 10.1001/archinte.168.10.1097 Yao, 2009, Current concepts on the role of inflammation in COPD and lung cancer, Curr Opin Pharmacol, 9, 375, 10.1016/j.coph.2009.06.009 Yao, 2008, Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice, Am J Respir Cell Mol Biol, 39, 7, 10.1165/rcmb.2007-0342OC Yashima, 1997, Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas, Cancer Res, 57, 2373 Youlden, 2008, The International Epidemiology of Lung Cancer: geographical distribution and secular trends, J Thorac Oncol, 3, 819, 10.1097/JTO.0b013e31818020eb Young, 2009, Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence, Postgrad Med J, 85, 414, 10.1136/pgmj.2008.078477 Yu, 2009, Cause-specific mortality in long-term survivors of retinoblastoma, J Natl Cancer Inst, 101, 581, 10.1093/jnci/djp046 Zhang, 2007, Household air pollution from coal and biomass fuels in china: measurements, health impacts, and interventions, Environ Health Perspect, 115, 848, 10.1289/ehp.9479 Zhang, 2006, Xenobiotic-metabolizing enzymes in human lung, Curr Drug Metab, 7, 939, 10.2174/138920006779010575 Zhang, 2007, Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways, Clin Cancer Res, 13, 4686, 10.1158/1078-0432.CCR-06-2898